
Viruses | Highly Cited Papers Published in 2025 in the “Viral Immunology, Vaccines, and Antivirals” Section
1. “Mpox 2022 to 2025 Update: A Comprehensive Review on Its Complications, Transmission, Diagnosis, and Treatment”
by Rajesh Yadav, Anis Ahmad Chaudhary, Ujjwal Srivastava, Saurabh Gupta, Sarvesh Rustagi, Hassan Ahmed Rudayni, Vivek Kumar Kashyap and Sanjay Kumar
Viruses 2025, 17(6), 753; https://doi.org/10.3390/v17060753
Available online: https://www.mdpi.com/1999-4915/17/6/753
2. “Current Dengue Virus Vaccine Developments and Future Directions”
by Govindaraj Anumanthan, Bikash Sahay and Ayalew Mergia
Viruses 2025, 17(2), 212; https://doi.org/10.3390/v17020212
Available online: https://www.mdpi.com/1999-4915/17/2/212
3. “HIV, Inflammation, and Immunometabolism: A Model of the Inflammatory Theory of Disease”
by Eman Teer, Nyasha C. Mukonowenzou and M. Faadiel Essop
Viruses 2025, 17(6), 839; https://doi.org/10.3390/v17060839
Available online: https://www.mdpi.com/1999-4915/17/6/839
4. “SARS-CoV-2 Infection and Antiviral Strategies: Advances and Limitations”
by Vinicius Cardoso Soares, Isabela Batista Gonçalves Moreira and Suelen Silva Gomes Dias
Viruses 2025, 17(8), 1064; https://doi.org/10.3390/v17081064
Available online: https://www.mdpi.com/1999-4915/17/8/1064
5. “Deciphering Host–Virus Interactions and Advancing Therapeutics for Chronic Viral Infection”
by Majid Eslami, Neda Arjmand, Fatemeh Mahmoudian, Ali Babaeizad, Hamed Tahmasebi, Fahimeh Fattahi and Valentyn Oksenych
Viruses 2025, 17(3), 390; https://doi.org/10.3390/v17030390
Available online: https://www.mdpi.com/1999-4915/17/3/390
6. “A Comprehensive Review of the Development and Therapeutic Use of Antivirals in Flavivirus Infection”
by Aarti Tripathi, Shailendra Chauhan and Renu Khasa
Viruses 2025, 17(1), 74; https://doi.org/10.3390/v17010074
Available online: https://www.mdpi.com/1999-4915/17/1/74
7. “The Role of Sustained Type I Interferon Secretion in Chronic HIV Pathogenicity: Implications for Viral Persistence, Immune Activation, and Immunometabolism”
by Eman Teer, Nyasha C. Mukonowenzou and M. Faadiel Essop
Viruses 2025, 17(2), 139; https://doi.org/10.3390/v17020139
Available online: https://www.mdpi.com/1999-4915/17/2/139
8. “Combating White Spot Syndrome Virus (WSSV) in Global Shrimp Farming: Unraveling Its Biology, Pathology, and Control Strategies”
by Md. Iftehimul, Neaz A. Hasan, David Bass, Abul Bashar, Mohammad Mahfujul Haque and Morena Santi
Viruses 2025, 17(11), 1463; https://doi.org/10.3390/v17111463
Available online: https://www.mdpi.com/1999-4915/17/11/1463
9. “Antagonistic Trends Between Binding Affinity and Drug-Likeness in SARS-CoV-2 Mpro Inhibitors Revealed by Machine Learning”
by Anacleto Silva de Souza, Vitor Martins de Freitas Amorim, Eduardo Pereira Soares, Robson Francisco de Souza and Cristiane Rodrigues Guzzo
Viruses 2025, 17(7), 935; https://doi.org/10.3390/v17070935
Available online: https://www.mdpi.com/1999-4915/17/7/935
10. “Long Non-Coding RNA THRIL Promotes Influenza Virus Replication by Inhibiting the Antiviral Innate Immune Response”
by Mengying Chen, Jingyun Hu, Xinni Zhou, Ming Gao, Ning Li, Guihong Yang, Xiaojuan Chi and Song Wang
Viruses 2025, 17(2), 153; https://doi.org/10.3390/v17020153
Available online: https://www.mdpi.com/1999-4915/17/2/153
11. “Update: Immunotherapeutic Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma”
by Fangdi Sun and A. Dimitrios Colevas
Viruses 2025, 17(5), 712; https://doi.org/10.3390/v17050712
Available online: https://www.mdpi.com/1999-4915/17/5/712
12. “Inactivated Viral Vaccine BBV87 Protects Against Chikungunya Virus Challenge in a Non-Human Primate Model”
by Sarah L. Kempster, Deborah Ferguson, Claire Ham, Joanna Hall, Adrian Jenkins, Elaine Giles, Simon L. Priestnall, Alejandro Suarez-Bonnet, Pierre Roques, Roger Le Grand et al.
Viruses 2025, 17(4), 550; https://doi.org/10.3390/v17040550
Available online: https://www.mdpi.com/1999-4915/17/4/550
13. “Structural Virology: The Key Determinants in Development of Antiviral Therapeutics”
by Tanuj Handa, Ankita Saha, Aarthi Narayanan, Elsa Ronzier, Pravindra Kumar, Jitin Singla and Shailly Tomar
Viruses 2025, 17(3), 417; https://doi.org/10.3390/v17030417
Available online: https://www.mdpi.com/1999-4915/17/3/417
14. “Insights into the Currently Available Drugs and Investigational Compounds Against RSV with a Focus on Their Drug-Resistance Profiles”
by Alessia Magnapera, Anna Riccio, Antonio Curcio, Caterina Tramontozzi, Lorenzo Piermatteo, Stefano D’Anna, Stefano Alcaro, Claudia Alteri, Simone La Frazia, Anna Artese et al.
Viruses 2025, 17(6), 793; https://doi.org/10.3390/v17060793
Available online: https://www.mdpi.com/1999-4915/17/6/793
15. “Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study”
by Luca Rinaldi, Mauro Viganò, Alessia Ciancio, Alfredo Caturano, Vincenzo Messina, Grazia Anna Niro, Nicolina Capoluongo, Alessandro Loglio, Letizia Marinaro, Aldo Marrone et al.
Viruses 2025, 17(2), 251; https://doi.org/10.3390/v17020251
Available online: https://www.mdpi.com/1999-4915/17/2/251
Related Special Issues:
“Antiviral Resistance Mutations, 2nd Edition”
Guest Editors: Dr. Ilaria Vicenti and Dr. Francesco Saladini
Submission deadline: 31 December 2026
“Innate and Mucosal Immunity Against Viral Infections”
Guest Editor: Dr. Yinyan Yin
Submission deadline: 30 April 2027